Neuroprotective properties of curcumin in toxin-base animal models of Parkinson’s disease: a systematic experiment literatures review
Open Access
- 17 August 2017
- journal article
- research article
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 17 (1) , 1-10
Abstract
Curcumin (diferuloylmethane), a polyphenol extracted from the plant Curcuma longa, is widely used in Southeast Asia, China and India in food preparation and for medicinal purposes. Meanwhile, the neuroprotective actions of curcumin have been documented for experimental therapy in Parkinson’s disease (PD). In this study, we used a systematic review to comprehensively assess the efficacy of curcumin in experimental PD. Using electronic and manual search for the literatures, we identified studies describing the efficacy of curcumin in animal models of PD. We identified 13 studies with a total of 298 animals describing the efficacy of curcumin in animal models of PD. The methodological quality of all preclinical trials is ranged from 2 to 5. The majority of the experiment studies demonstrated that curcumin was more significantly neuroprotection effective than control groups for treating PD. Among them, five studies indicated that curcumin had an anti-inflammatory effect in the PD animal models (p < 0.05). Meanwhile, four studies showed the antioxidant capability of curcumin, by which it protected substantia nigra neurons and improved striatal dopamine levels. Furthermore, two studies in this review displayed that curcumin treatment was also effective in reducing neuronal apoptosis and improving functional outcome in animal models of PD. Most of the preclinical studies demonstrated the positive findings while one study reported that curcumin had no beneficial effects against Mn-induced disruption of hippocampal metal and neurotransmitter homeostasis. The results demonstrated a marked efficacy of curcumin in experimental model of PD, suggesting curcumin probably a candidate neuroprotective drug for human PD patients.Keywords
Funding Information
- National Natural Science Foundation of China (No.81600977)
This publication has 35 references indexed in Scilit:
- The pharmacology of curcumin: is it the degradation products?Trends in Molecular Medicine, 2012
- Curcumin I protects the dopaminergic cell line SH-SY5Y from 6-hydroxydopamine-induced neurotoxicity through attenuation of p53-mediated apoptosisNeuroscience Letters, 2011
- Specific Inhibition of NEIL-initiated Repair of Oxidized Base Damage in Human Genome by Copper and IronJournal of Biological Chemistry, 2010
- Update of the Stroke Therapy Academic Industry Roundtable Preclinical RecommendationsStroke, 2009
- Incidence and remaining lifetime risk of Parkinson disease in advanced ageNeurology, 2009
- Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030Neurology, 2007
- CURCUMIN: THE INDIAN SOLID GOLD2007
- Inhibitory effect of curcumin on nitric oxide production from lipopolysaccharide-activated primary microgliaLife Sciences, 2006
- Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl-2-mitochondria-ROS-iNOS pathwayApoptosis, 2006
- Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug DevelopmentStroke, 1999